Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Mercury Laboratories Ltd

NSE: MERCURYLAB · BSE: 538964 · Pharmaceuticals & Biotechnology · 21 announcements

Share price
₹765.00
Market cap
₹91.80 Cr
Revenue (annual)
₹75.94 Cr
Net profit (annual)
₹4.83 Cr
P/E (TTM)
22.1×Sector 47.3×
Promoter holding
73.66%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:57 IST BSE
Other Announcement

Mercury Laboratories Other Announcement

Mercury Laboratories informs shareholders regarding Tax Deduction at Source (TDS) requirements for the FY 2025-26 dividend. This communication outlines necessary compliance and record-updating procedures.

19:53 IST BSE
Other Announcement

Mercury Laboratories Other Announcement

Mercury Laboratories filed its Annual Secretarial Compliance Report for the financial year 2025-26. The report by Dholakia & Associates confirms no material non-compliance or penalties.

14:52 IST BSE
Other Announcement

Mercury Laboratories Other Announcement

Mercury Laboratories Ltd has issued an intimation regarding the mandatory transfer of equity shares to the IEPF Authority. This applies to shareholders who have not claimed dividends for seven consecutive years starting from FY 2018-19. Shareholders must claim their unclaimed dividends by November 02, 2026, to avoid the share transfer.

17:24 IST BSE
Other Announcement

Mercury Laboratories Other Announcement

Mercury Laboratories Ltd submitted its quarterly confirmation certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period ended March 31, 2026. The registrar, MUFG Intime India, confirmed that security certificates received for dematerialisation were processed and listed on the relevant exchanges within prescribed timelines.